Akers Biosciences Cm (AKER) 1.92 $AKER Akers Biosciences

New Post Public Reply Private Reply Replies (0) Message Board

Jun 10, 2016 at 10:23 AM

Akers Biosciences Cm (AKER) 1.92 $AKER

Akers Biosciences to Present at LD Micro Invitational Conference
Marketwire Canada - Fri Jun 03, 8:52AM CDT
THOROFARE, NJ--(Marketwired - Jun 3, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) (the "Company"

, a developer of rapid health information technologies, announces that Co-founder and Chief Scientific Director, Raymond F. Akers, Jr. PhD, will present to investors attending the upcoming LD Micro Invitational Conference in Los Angeles, CA. on Tuesday June 7, 2016. Dr. Akers intends to provide an update on the Company's business including the increasing traction in the US and China of the Company's flagship rapid test for Heparin-induced thrombocytopenia.
AKER: 1.92 (-0.16)

Akers (AKER) Reports Q1 Earnings; Product Revenue Up 79.3%
Aparajita Dutta - Zacks Investment Research - Thu May 12, 7:46AM CDT
Akers' (AKER) first-quarter product revenue increased 79.3% from the year-ago quarter to $738,023
AKER: 1.92 (-0.16)

Akers Biosciences Reports Earnings for Q1 2016
Marketwire Canada - Thu May 12, 6:00AM CDT
PIFA Heparin/PF4 Rapid Tests Sales Up 88%; Total Revenues up 45%
AKER: 1.92 (-0.16), AKR: 34.06 (-0.15)

Akers Biosciences Announces Conference Call to Discuss Q1 2016 Earnings
Marketwired - Tue May 10, 6:00AM CDT
THOROFARE, NJ--(Marketwired - May 10, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, will hold a conference call on Thursday, May 12, 2016 at 09:00 a.m. Eastern Time to discuss its earnings for the first quarter ended March 31, 2016, which will be published earlier that day. Management will be available during a question-and-answer session.
AKER: 1.92 (-0.16)

Akers Biosciences (AKER) Q1 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:52AM CDT
Akers Biosciences Inc (AKER) is expected to report first-quarter 2016 results on May 12.
CAPR: 3.23 (-0.28), STAA: 5.42 (-0.07), AKER: 1.92 (-0.16), VBLT: 4.73 (-0.07)

Akers Biosciences to Present at 'Pioneers 2016' Investor Conference
Marketwire Canada - Wed May 04, 1:00PM CDT
THOROFARE, NJ--(Marketwired - May 4, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company"

, a developer of rapid health information technologies, is presenting at Joseph Gunnar & Co., LLC's 'Pioneers 2016' conference in New York on May 5, 2016.
AKER: 1.92 (-0.16), AKR: 34.06 (-0.15)

Akers Board Rearrangement
Marketwired - Fri Apr 29, 6:01AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, announces changes to the roles of certain board members, which take effect immediately and are designed to improve the effectiveness of the Board of Directors.
AKER: 1.92 (-0.16)

Akers' Loss Widens in 2015, Revenues Deteriorate Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 9:46AM CDT
Akers Biosciences Inc. (AKER) reported loss of $1.81 per share in full-year 2015, much wider than 66 cents recorded in 2014.
AMZN: 721.88 (-5.77), BAX: 44.18 (-0.57), AKER: 1.92 (-0.16), HRC: 50.87 (-0.35)

Akers Biosciences Reports Earnings for Fiscal Year 2015
Marketwired - Wed Mar 30, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, reports its financial results for the fiscal year ended December 31, 2015.
AKER: 1.92 (-0.16)

What Awaits Akers Biosciences (AKER) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 8:10AM CDT
Akers Biosciences Inc (AKER) is expected to report fourth-quarter 2015 earnings results on Mar 30.
AMZN: 721.88 (-5.77), AXDX: 14.45 (+0.13), AKER: 1.92 (-0.16)

Akers Biosciences' Protein Preparation Gets Patent Cover
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 9:10AM CDT
Akers Biosciences Inc. (AKER) recently won a patent from the United States Patent and Trademark Office (USPTO) for its proprietary protein preparation.
BAX: 44.18 (-0.57), LMAT: 14.83 (-0.26), AKER: 1.92 (-0.16), HRC: 50.87 (-0.35)

Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection
Marketwired - Wed Mar 23, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, announces that the United States Patent and Trademark Office has allowed a patent covering Akers Bio's proprietary methods for detecting heparin/platelet factor 4 antibodies (the "Patent"

.
AKER: 1.92 (-0.16)

Akers Biosciences Announces Conference Call to Discuss Its 2015 Earnings
Marketwired - Wed Mar 16, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company"

, a developer of health information technologies, will hold a conference call on Wednesday, March 30, 2016 at 09:00 a.m. Eastern Time to discuss its earnings, which will be published earlier that day, for the fiscal year ended December 31, 2015.
AKER: 1.92 (-0.16)

Akers Receives Order for Rapid Assays in China; Shares Rise
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 1:20PM CST
Shares of Akers Biosciences (AKER) rallied 11.2% (19 cents) on Mar 2, following the announcement of an order to supply PIFA Heparin PF4/Rapid Assay products in China.
ABMD: 102.48 (-1.83), AKER: 1.92 (-0.16), LMNX: 20.31 (-0.49), CRY: 11.85 (-0.13)

Akers Biosciences to Present at Disruptive Growth & Healthcare Conference
GlobeNewswire - Mon Feb 08, 11:18AM CST
Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"

, a developer of cutting edge technologies that deliver rapid health information, is presenting at Source Capital's 2016 Disruptive Growth & Healthcare conference in New York on February 10, 2016.
AKER: 1.92 (-0.16)

Akers Biosciences JV Facility Now Operational in China
Zacks Equity Research - Zacks Investment Research - Thu Dec 03, 11:50AM CST
Akers Biosciences (AKER) recently announced that its Chinese joint venture's 10000 square foot production facility is now fully operational.
ICUI: 107.81 (-0.32), AMZN: 721.88 (-5.77), NXTM: 20.74 (-0.25), AKER: 1.92 (-0.16)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CME Group Unveils First Baseball Futures Market

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Ingram Mercantile's Aviation Push: SCORE or Sink?

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Teamsters Secure Landmark Deal for SF Parking Workers

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

Ajman Tourism Department Hits Internal Audit Milestone

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Moore, Schulman & Moore Attorneys Earn Top Honors Again

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

Rutter Mills Secures $13M in Virginia Injury Cases

The Stakes in Virginia When you drop nine successful injury cases on the scales and they tip over $13 million, that's a story worth dissecting. The two top dogs at Rutter Mills certainly know how to make a splash in the legal puddle, don't they? We're talking about attorneys Adam H. Lotkin and Georgina D. Montgomery here, the legal eagles behind these jaw-dropping...

Steel Dynamics Gears Up for Q3 2026 Earnings Update

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Hexaware Teams with Anthropic for Game-Changing AI Move

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Striveworks: Boosting Army's AI Edge in Indo-Pacific

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...